Clinical trial
Telmisartan as an Adjunctive Treatment for Metabolic Problems in Patients With Schizophrenia
NCT00981526
Study timeline
Study start (unknown)2009-03-01Date precision: month
Registry last updated2018-06-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Schizoaffective Disorderunresolved
Interventions
TelmisartanDRUG · verified · RxNorm: telmisartan
PlaceboDRUG
ClozapineDRUG · verified · RxNorm: clozapine
OlanzapineDRUG · verified · RxNorm: olanzapine
Sponsors & collaborators
University of Massachusetts, Worcesterlead sponsor
National Institutes of Health (NIH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00981526 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.